Home » Expert Content » Drug Substance Manufacturing » A Strategy to Standardize Process Characterization & Late Phase Development – Cell Culture Optimization

A Strategy to Standardize Process Characterization & Late Phase Development – Cell Culture Optimization

Summary: Process characterization is an important step in the overall journey of product development. For therapies that have had early success in the clinic and are progressing toward commercial manufacturing, understanding the operational, regulatory and quality connections is critical for successful filing and launch. This case study proposes an approach for process characterization for the production of a monoclonal antibody, specifically at the drug substance biomanufacturing step.

Click here to view the Case Study

Related Topics